China In-Licensing Model Still Has Profitable Legs: LianBio CEO

 
• By Dexter Jie Yan
sales ramp-up
LianBio girds loins for plunge into Asian hypertrophic cardiomyopathy market • Source: Shutterstock

More from China

More from Focus On Asia